Table 1. MST loci that can precisely differentiate between the lung cancer samples and non-tumor samples.
Genomic position | Repeat | Gene region | Gene | Entrez ID | Disease | Odds ratio |
---|---|---|---|---|---|---|
chr2:60918364-60918376 | T | Intron | REL | 5966 | LUAD, LUSC | 39.92 |
chr6:157174818-157174831 | T | Intron | ARID1B | 57 492 | LUAD, LUSC, MB, SKCM | 13.57 |
chr6:76018867-76018880 | A | Intron | IMPG1 | 3617 | LUSC, OV | 12.28 |
chr3:94035443-94035458 | T | Intron | ARL13B | 200 894 | GBM, LUAD, SKCM | 11.20 |
chr3:112534347-112534360 | A | Intron | ATG3 | 64 422 | GBM, LGG, LUAD, LUSC | 10.29 |
chr8:129862369-129862381 | A | Intron | FAM49B | 51 571 | LUAD, LUSC | 7.01 |
chr9:130622843-130622857 | A | Intron | FUBP3 | 8939 | GBM, LGG, LUAD, LUSC, MB, OV | 6.93 |
chr7:135414296-135414309 | A | Intron | CNOT4 | 4850 | LUAD | 5.07 |
chr2:48461120-48461133 | T | Intron | KLRAQ1 | 129 285 | LGG, LUAD, LUSC, MB, SKCM | 4.43 |
chr2:55332516-55332530 | A | Intron | CCDC88A | 55 704 | LUAD, LUSC, SKCM | 3.90 |
chr13:31148484-31148500 | A | Intron | HSPH1 | 3315 | LUAD, SKCM | 3.70 |
chr15:20458509-20458521 | A | Intron | HERC2P3 | 283 755 | LUAD | 3.00 |
chr10:13591929-13591943 | T | Intron | PRPF18 | 8559 | LUSC | 2.25 |
chr2:202815832-202815844 | A | Intron | ICA1L | 130 026 | BC, GBM, OV | 7.61 |
chr13:114236623-114236635 | T | Intron | CDC16 | 8881 | LGG, SKCM | 6.19 |
chr12:106106383-106106396 | A | Intron | NUAK1 | 9891 | OV | 5.74 |
chr3:98580864-98580876 | A | Intron | CPOX | 1371 | BC, OV | 5.02 |
chr16:70839964-70839978 | T | Intron | HYDIN | 54 768 | GBM | 4.58 |
chr2:233460070-233460083 | A | Intron | DGKD | 8527 | OV | 3.82 |
chr5:87383860-87383873 | T | Intron | RASA1 | 5921 | OV | 2.93 |
chr8:23852057-23852082 | TG | Intron | STC1 | 6781 | BC | 1.87 |
Abbreviations: GBM, glioblastoma; LGG, lower grade glioma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma. MB, medulloblastoma; OV, ovarian cancer; SKCM, skin cutaneous melanoma.